Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
PUT
HealthEquity
HQY
$8.83B
| $66K | ﹤0.01% |
+1,100
| New | +$88.7K |
|
5202
CALL
InterDigital
IDCC
$8.72B
| $66K | ﹤0.01% |
1,000
-1,100
| -52% | -$80.1K |
|
5203
Insmed
INSM
$29B
| $66K | ﹤0.01% |
5,030
-31,251
| -86% | -$499K |
|
5204
Liberty Latin America Class A
LILA
$1.68B
| $66K | ﹤0.01% |
7,217
-28,590
| -80% | -$330K |
|
5205
PUT
ProShares Short S&P500
SH
$846M
| $66K | ﹤0.01% |
525
+500
| +2,000% | +$58.9K |
|
5206
PUT
Texas Roadhouse
TXRH
$13.8B
| $66K | ﹤0.01% |
1,100
-400
| -27% | -$25.7K |
|
5207
Vanguard FTSE Europe ETF
VGK
$31B
| $66K | ﹤0.01% |
1,362
| – | – |
|
|
VTLE
5208
PUT
DELISTED
Vital Energy
VTLE
| $66K | ﹤0.01% |
+910
| New | +$95.5K |
|
5209
CALL
WisdomTree
WT
$3.33B
| $66K | ﹤0.01% |
9,900
+2,600
| +36% | +$18.9K |
|
5210
PUT
Ameren
AEE
$29.8B
| $65K | ﹤0.01% |
1,000
+900
| +900% | +$60K |
|
5211
PUT
Amphenol
APH
$206B
| $65K | ﹤0.01% |
3,200
-11,600
| -78% | -$249K |
|
5212
CALL
Cheesecake Factory
CAKE
$5.63B
| $65K | ﹤0.01% |
1,500
-400
| -21% | -$19.4K |
|
|
CEPU
5213
Central Puerto
CEPU
$2B
| $65K | ﹤0.01% |
7,100
| – | – |
|
5214
CALL
Corcept Therapeutics
CORT
$12.1B
| $65K | ﹤0.01% |
+4,900
| New | +$64.8K |
|
|
5215
PUT
Corcept Therapeutics
CORT
$12.1B
| $65K | ﹤0.01% |
+4,900
| New | +$64.8K |
|
5216
CALL
Cenovus Energy
CVE
$55B
| $65K | ﹤0.01% |
9,300
-300
| -3% | -$2.47K |
|
5217
CALL
Crane NXT
CXT
$2.95B
| $65K | ﹤0.01% |
2,591
+576
| +29% | +$17.1K |
|
5218
PUT
Diodes
DIOD
$4.75B
| $65K | ﹤0.01% |
2,000
+1,600
| +400% | +$51.1K |
|
5219
PUT
Prologis
PLD
$133B
| $65K | ﹤0.01% |
1,100
+300
| +38% | +$19.4K |
|
5220
ROBO Global Robotics & Automation Index ETF
ROBO
$2.1B
| $65K | ﹤0.01% |
2,002
| – | – |
|
5221
PUT
Sempra
SRE
$55.9B
| $65K | ﹤0.01% |
+1,200
| New | +$68.4K |
|
|
SYBX
5222
DELISTED
Synlogic
SYBX
| $65K | ﹤0.01% |
617
-379
| -38% | -$49.9K |
|
5223
Zai Lab
ZLAB
$2.92B
| $65K | ﹤0.01% |
+2,790
| New | +$51.7K |
|
|
CSLT
5224
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $65K | ﹤0.01% |
30,032
+591
| +2% | +$1.47K |
|
|
ONDK
5225
DELISTED
On Deck Capital, Inc.
ONDK
| $65K | ﹤0.01% |
10,948
-23,068
| -68% | -$164K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.